CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• CRISPR/Cas9 is a prokaryotic immune system adapted for eukaryotic genome editing.
• Targeted gene knock-out is challenging in neuroscience due to cellular adaptation.
• CRISPR/Cas9 enables precise DNA double-strand breaks for gene inactivation.

Purpose of the Study:

• To demonstrate CRISPR/Cas9-mediated gene knock-out in mouse pyramidal neurons.
• To investigate the function of the NMDA receptor subunit GluN1 in neuronal circuits.
• To establish CRISPR/Cas9 as a tool for studying gene function in vivo.

Main Methods:

• Utilized CRISPR/Cas9 technology for targeted gene editing.
• Focused on knocking out Grin1, the gene for GluN1 NMDA receptor subunit.
• Generated sparse neuronal populations with genetic modifications in vivo.

Main Results:

• Achieved successful knock-out of the Grin1 gene in a subset of neurons.
• Demonstrated a lack of NMDA receptor-mediated synaptic current in manipulated cells.
• Provided the first proof-of-principle for CRISPR/Cas9-mediated gene knock-down in neurons.

Conclusions:

• CRISPR/Cas9 is effective for targeted gene knock-out in neurons.
• This technique facilitates the study of specific protein functions in neuronal circuits.
• CRISPR/Cas9 offers a valuable tool for neuroscience research in vivo.